Sanofi warns on '13 profit as Q2 earns slump

PARIS (AP) — Competition from generic drugs continued to hammer French pharmaceutical group Sanofi in the second quarter, the company said Thursday, warning that its full-year earnings could be twice as bad as previous guidance.